NCT01344083已完成2 期
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Change from baseline of the score of tearing
研究概览
简要总结
The aim of this study is to compare the efficacy and the safety of T1210 versus Olopatadine eye drops in the topical treatment of seasonal allergic conjunctivitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •Conjunctivitis allergic conjunctivitis
排除标准
- •Severe ocular allergy
- •Vernal keratoconjunctivitis
研究组 & 干预措施
T1210
Experimental
干预措施: T1210 (Drug)
Olopatadine hydrochloride
Active Comparator
干预措施: Olopatadine hydrochloride (Drug)
结局指标
主要结局
Change from baseline of the score of tearing
时间窗: Day 28
Change from baseline of the score of itching
时间窗: Day 28
Change from baseline of the score of conjunctival hyperaemia
时间窗: Day 28
次要结局
- Global local tolerance assessment by the Investigator and the patient(Day 28)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial ConjunctivitisConjunctivitis, BacterialNCT00357773Laboratoires Thea
已完成
3 期
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of TrachomaTrachomaNCT00356720Laboratoires Thea
已完成
2 期
Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisBlepharitisNCT04475432Tarsus Pharmaceuticals, Inc.421
已完成
1 期
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy VolunteersEye Infections, BacterialNCT00357383Laboratoires Thea
已完成
3 期
Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisBlepharitisNCT04784091Tarsus Pharmaceuticals, Inc.412